A
Power Law company profile
ARS Pharmaceuticals
Biotech & Life Sciences · San Diego, United States · Founded 2015 Unicorn
Global footprint
Where ARS Pharmaceuticals has talent and traffic
Web traffic by country
20K
monthly visits
across markets
across markets
🇺🇸 United States61.5%
🇮🇳 India15.5%
🇨🇦 Canada8%
🇬🇧 United Kingdom7.5%
🇵🇭 Philippines5.5%
Patent intelligence
$7M patent portfolio · 5 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$7M
1.1% of valuation · 41.6× smaller than top peer argenx ($275M)
5 active patent families
Where ARS Pharmaceuticals innovates
Molecular biologyCancer researchAntiendomysial antibodiesPharmaceutical drugAntibody conjugate
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
ARS Pharmaceuticals on the five Patsnap quality dimensions
ARS Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where ARS Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across ARS Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee ARS Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.